Volume 7 - Issue 3 - Winter 2017



A Hometown Cancer Breakthrough

You might not imagine an important new breakthrough in immunotherapy for ovarian cancer could be developed in Tyler or Bedford, but significant cancer research is taking place outside of academic research institutions. More community-based research, long a focus of Texas Oncology, is an important priority for former Vice President Joe Biden’s ‘Cancer Moonshot’ initiative.

Texas Oncology enrolls about 2,000 patients annually in clinical trials, including Carol Houston, a Waco lung cancer patient who described her clinical trial experience:

Carol Houston
Lung cancer patient,
Texas Oncology-Waco

Inoperable stage IV lung cancer. A diagnosis I never expected, but it was my reality.

After starting chemo, Dr. Thomas Harris of Texas Oncology−Waco offered a clinical trial locally. It gave me access to a new medicine that interferes with the growth and spread of cancer cells. It had limited side effects and I’m now stable.

Receiving care close to home was very important to me. I live here. I work here. Participating in a clinical trial shouldn’t require traveling across the state or country.

I have two children, five grandchildren, and one great grandchild. Texas Oncology gave me more opportunity to enjoy every second I can with them.